Nevralon 50 mg/50 mg/0,5 mg/ml soluție injectabilă Moldova - Romanian - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

nevralon 50 mg/50 mg/0,5 mg/ml soluție injectabilă

world medicine ltd - thiaminum + pyridoxinum + cyanocobalaminum - soluție injectabilă - 50 mg/50 mg/0,5 mg/ml

Nyxthracis (previously Obiltoxaximab SFL) European Union - Romanian - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - seruri imune și imunoglobuline, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.